The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia

Benign prostatic hyperplasia (BPH) is characterized by an enlarged prostate, lower urinary tract symptoms (LUTS), and a decreased urinary flow rate. Common in older men, BPH is a progressive disease that can eventually lead to complications including acute urinary retention (AUR) and the need for BP...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eric H., Brockman, John A., Andriole, Gerald L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Military Medical University 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780290/
https://www.ncbi.nlm.nih.gov/pubmed/29379733
http://dx.doi.org/10.1016/j.ajur.2017.11.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780290/
https://www.ncbi.nlm.nih.gov/pubmed/29379733
http://dx.doi.org/10.1016/j.ajur.2017.11.005

Ejemplares similares